Gavin Corcoran serves as Executive at Axovant Gene Therapies Ltd., where they oversee executive responsibilities. Since joining the company, Gavin Corcoran has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 17, 2021 involved receiving (via award) 16,001 shares valued at $0.
Gavin Corcoran currently holds 25,792 shares of Axovant Gene Therapies Ltd. (AXGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gavin Corcoran has been a net neutral trader of AXGT stock. They have purchased $0 and sold $0 worth of shares.
Gavin Corcoran's most recent insider trade was on Mar 17, 2021, when they sold 16,001 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 12, 2020 | AXGT | $21.5K | Payment | 6,211 | $3.46 | Discretionary |